211 related articles for article (PubMed ID: 2958199)
1. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.
Paccaud JP; Steiger G; Sjöholm AG; Spaeth PJ; Schifferli JA
Clin Exp Immunol; 1987 Aug; 69(2):468-76. PubMed ID: 2958199
[TBL] [Abstract][Full Text] [Related]
2. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
3. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
4. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
Sherwood TA; Virella G
Clin Exp Immunol; 1986 Apr; 64(1):195-204. PubMed ID: 3731526
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
6. Immune adherence and staphylococcus protein A binding of soluble immune complexes produced by complement activation.
Schifferli JA; Peters DK
Clin Exp Immunol; 1983 Dec; 54(3):827-33. PubMed ID: 6228359
[TBL] [Abstract][Full Text] [Related]
7. Control of immune complexes by the classical pathway.
Whaley K; Ahmed AE
Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
Taylor RP; Kujala G; Wilson K; Wright E; Harbin A
J Immunol; 1985 Apr; 134(4):2550-8. PubMed ID: 3919101
[TBL] [Abstract][Full Text] [Related]
9. [Elimination of immune complexes: role of complement].
Schifferli JA
Schweiz Med Wochenschr; 1985 Oct; 115(41):1422-4. PubMed ID: 2933806
[TBL] [Abstract][Full Text] [Related]
10. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
Varga L; Thiry E; Füst G
Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the endocytosis of immune complexes.
van Es LA; Daha MR
Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
[TBL] [Abstract][Full Text] [Related]
12. A complement receptor for opsonized immune complexes on erythrocytes from Oncorhynchus mykiss but not Ictalarus punctatus.
Schraml B; Baker MA; Reilly BD
Mol Immunol; 2006 Apr; 43(10):1595-603. PubMed ID: 16271392
[TBL] [Abstract][Full Text] [Related]
13. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
Edberg JC; Wright E; Taylor RP
J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
[TBL] [Abstract][Full Text] [Related]
15. Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement.
Kijlstra A; van Es LA; Daha MR
Immunology; 1981 Jun; 43(2):345-52. PubMed ID: 7251057
[TBL] [Abstract][Full Text] [Related]
16. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
Geha RS
J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
[TBL] [Abstract][Full Text] [Related]
17. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
[TBL] [Abstract][Full Text] [Related]
18. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
19. Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B.
Schifferli JA; Hauptmann G; Paccaud JP
FEBS Lett; 1987 Mar; 213(2):415-8. PubMed ID: 3493921
[TBL] [Abstract][Full Text] [Related]
20. Non-complement-dependent adsorption of soluble immune complexes to human red cells.
Virella G; Shuler CW; Sherwood T
Clin Exp Immunol; 1983 Nov; 54(2):448-54. PubMed ID: 6652968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
